HOME >> BIOLOGY >> NEWS
Can female adult obesity be stopped at birth?

July 29, 2003 -- Bethesda, MD American society today wants things fixed instantly. Among the most prominent searches for the "quick fix" is weight loss. Could our own physiology rather than a purchased liquid concoction one day be the key to female obesity? Perhaps.

Background

The body's energy homeostasis is maintained by a highly complex and integrated neurohormonal system that minimizes fluctuations in energy balance. Neurohormones are formed by neurosecretory cells and liberated by nerve impulses (e.g., norepinephrine). Their contribution towards this energy balance includes hormonal secretion sometimes in proportion to the body fat mass and the central nervous system (CNS) targets on which these hormones act.

Of the CNS targets, a complex array of hypothalamic neuropeptides constitutes the appetite regulation system. Of these neuropeptides, NPY, a 36-amino acid orexigenic peptide, is released at the nerve terminals. In the adult rat, NPY has been observed to play a key role in affecting hyperphagia (gluttony) with resultant obesity. Various hormones orchestrate the synthesis and release of this neuropeptide. For example, pancreatic insulin and leptin released by adipocytes have been reported to suppress the synthesis and release of hypothalamic NPY, thereby potentially forming a feedback system in regulating appetite, feeding behavior, and energy balance.

A previous study demonstrated that disturbances in the fetal metabolic environment of diabetic rat or an intrauterine growth-restricted (IUGR) fetus can also alter postnatal brain NPY mRNA and peptide concentrations. This, and other research, demonstrated the presence and regulation of NPY in the fetal and neonatal hypothalamus, yet the exact functional role of this peptide during the early stages of development remains to be ascertained. Accordingly, the functional relevance of a postnatal increase in hypothalamic NPY as seen in the IUGR fetus/newborn is unknown.

A
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
29-Jul-2003


Page: 1 2 3 4 5

Related biology news :

1. When male fish hum, females swim in, thanks to hormones, adaptable hearing
2. Feeding cottonseed meal to female fallow deer safe at low rates
3. For a male sand goby, playing Mr. Mom is key to females heart
4. MGH study finds female mammals produce egg cells into adulthood
5. Link between alcohol consumption and muscle damage in females
6. OHSU researchers reveal relationship between weight gain and female hormones
7. Male flesh flies high-speed pursuit of females
8. Are the bright colors of some avian eggs signaling female genetic quality to their mates?
9. Chlamydia infection prevalent among female army recruits
10. Newly mapped enzyme could yield new treatments for female sexual dysfunction
11. Four gene micronet found to regulate social behavior in female mice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Can female adult obesity stopped birth

(Date:2/24/2015)... DUBLIN , Feb. 24, 2015 Research ... announced the addition of the "Global 2D ... offering. The analysts forecast the ... a CAGR of 32.12% over the period 2014-2019 ... devices in non-traditional sectors is one of the ...
(Date:2/13/2015)... -- ACT Genomics Co., Ltd., a cancer molecular ... genomic information into precision diagnosis and personalized treatments, ... million in the its first private funding round. ... , ACT Genomics has developed comprehensive cancer ... implement next generation sequencing (NGS) and multiplex molecular ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
(Date:2/27/2015)... 2015 A paper published today, " ... " in Science Translational Medicine, demonstrates ... reduce the risk associated with investing in the ... levels of funding for developing so-called "orphan" drugs. ... collaboration between scientists at the National Center for ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited ... the DisrupTOR-1 trial of BNC105 in patients with metastatic ... Orlando, Florida . The data will ... the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 ...
(Date:2/27/2015)... 2015 FamilyFarms Group is pleased to ... State Line Farms, received the 2015 Tomorrow’s Top Producer ... the age of 35, who has demonstrated excellence in ... to win the Tomorrow's Top Producer Horizon Award. Every ... Top Producer Award and learning from their experiences. It ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
Cached News: